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Abstract
We apply optimal control theory to a tuberculosis model given by a system of ordinary
differential equations. Optimal control strategies are proposed to minimize the cost of in-
terventions, considering reinfection and post-exposure interventions. They depend on the
parameters of the model and reduce effectively the number of active infectious and persistent
latent individuals. The time that the optimal controls are at the upper bound increase with
the transmission coefficient. A general explicit expression for the basic reproduction number
is obtained and its sensitivity with respect to the model parameters is discussed. Numerical
results show the usefulness of the optimization strategies.
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1 Introduction
Mycobacterium tuberculosis is the cause of most occurrences of tuberculosis (TB) and is usually
acquired via airborne infection from someone who has active TB. It typically affects the lungs
(pulmonary TB) but can affect other sites as well (extrapulmonary TB). Only approximately
10% of people infected with mycobacterium tuberculosis develop active TB disease. Therefore,
approximately 90% of people infected remain latent. Latent infected TB people are asymptomatic
and do not transmit TB, but may progress to active TB through either endogenous reactivation
or exogenous reinfection [21, 22].
Without treatment, mortality rates are high, but the anti-TB drugs developed since 1940
dramatically reduce mortality rates (in clinical cases, cure rates of 90% have been documented)
[26]. However, TB remains a major health problem. In 2010 there were an estimated 8.5 to 9.2
million cases and 1.2 to 1.5 million deaths. TB is the second leading cause of death from an
infectious disease worldwide after HIV [26].
One can distinguish three types of TB treatment: vaccination to prevent infection; treatment
to cure active TB; treatment of latent TB to prevent endogenous reactivation [12]. The treatment
of active infectious individuals can have different timings [16]. Here we consider treatment with
the duration of six months. In these treatments one of the difficulties to their success is to make
sure that the patients complete the treatment. Indeed, after two months, patients no longer have
symptoms of the disease and feel healed, and many of them stop taking the medicines. When
the treatment is not concluded, the patients are not cured and reactivation can occur and/or the
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patients may develop resistent TB. One way to prevent patients of not completing the treatment
is based on supervision and patient support. In fact, this is one of the measures proposed by the
Direct Observation Therapy (DOT) of World Health Organization (WHO) [25]. One example of
treatment supervision consists in recording each dose of anti-TB drugs on the patients treatment
card [25]. These measures are very expensive since the patients need to stay longer in the hospital
or specialized people are to be payed to supervise patients till they finish their treatment. On the
other hand, it is recognized that the treatment of latent TB individuals reduces the chances of
reactivation, even if it is still unknown how treatment influences reinfection [12].
Optimal control is a branch of mathematics developed to find optimal ways to control a dynamic
system [6, 11, 18]. While the usefulness of optimal control theory in epidemiology is nowadays
well recognized [17, 19, 20], results in tuberculosis are scarce [14]. Recently, different optimal
control problems applied to TB have been proposed and analyzed [3, 9, 13]. The first paper
appeared in 2002 [14], and considers a mathematical model for TB based on [5] with two classes
of infected and latent individuals (infected with typical TB and with resistant strain TB) where
the aim is to reduce the number of infected and latent individuals with resistant TB. In [9] the
model considers the existence of a class called the lost to follow up individuals and they propose
optimal control strategies for the reduction of the number of individuals in this class. In [13] the
authors adapt a model from [10] where exogenous reinfection is considered and wish to minimize
the number of infectious individuals. In [3] a TB model that incorporates exogenous reinfection,
chemoprophylaxis of latently infected individuals and treatment of infections is proposed. Optimal
control strategies based on chemoprophylaxis of latently infected individuals and treatment of
infectious individuals are analyzed for the reduction of the number of active infected individuals.
Our aim is to study optimal strategies for the minimization of the number of active TB infectious
and persistent latent individuals, taking into account the cost of the measures for the treatments
of these individuals. For that, we study the mathematical model for TB dynamics presented
in [12], where reinfection and post-exposure interventions are considered. The importance of
considering reinfection and post-exposure interventions is justified in [2, 4, 12, 24]. In Section 2
we modify the model of [12] adding two controls u1(t) and u2(t), which are functions of time t,
and two real positive parameters, ǫ1 and ǫ2. We also explain the meaning of these and the other
parameters of the TB model. A sensitivity analysis for the basic reproduction number is given in
Section 3. In Section 4 we formulate the optimal control problem. We prove that the problem has
an unique solution, and finally we apply to it the celebrated Pontryagin Maximum Principle [18].
In Section 5 we propose optimal control strategies, obtained by numerical simulations, considering
several variations of some of the parameters of the TB model. We end with Section 6 of conclusion.
2 TB model with controls
We study the mathematical model from [12] where reinfection and post-exposure interventions
are considered. We add to that model two control functions u1(·) and u2(·) and two real positive
parameters ǫ1 and ǫ2. The resulting model is given by the following system of nonlinear ordinary
differential equations:


S˙(t) = µN − βN I(t)S(t)− µS(t)
L˙1(t) =
β
N I(t) (S(t) + σL2(t) + σRR(t))− (δ + τ1 + µ)L1(t)
I˙(t) = φδL1(t) + ωL2(t) + ωRR(t)− (τ0 + ǫ1u1(t) + µ)I(t)
L˙2(t) = (1− φ)δL1(t)− σ
β
N I(t)L2(t)− (ω + ǫ2u2(t) + τ2 + µ)L2(t)
R˙(t) = (τ0 + ǫ1u1(t))I(t) + τ1L1(t) + (τ2 + ǫ2u2(t))L2(t)− σR
β
N I(t)R(t)− (ωR + µ)R(t).
(1)
The population is divided into five categories (i.e., control system (1) has five state variables):
susceptible (S); early latent (L1), i.e., individuals recently infected (less than two years) but not
infectious; infected (I), i.e., individuals who have active TB and are infectious; persistent latent
(L2), i.e., individuals who were infected and remain latent; and recovered (R), i.e., individuals
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who were previously infected and treated. The control u1 represents the effort that prevents the
failure of treatment in active TB infectious individuals I, e.g., supervising the patients, helping
them to take the TB medications regularly and to complete the TB treatment. The control
u2 represents the fraction of persistent latent individuals L2 that is identified and put under
treatment. The parameters ǫi, ǫi ∈ (0, 1), i = 1, 2, measure the effectiveness of the controls ui,
i = 1, 2, respectively, i.e., these parameters measure the efficacy of treatment interventions for
active and persistent latent TB individuals, respectively.
Following [12], we assume that at birth all individuals are equally susceptible and differentiate
as they experience infection and respective therapy. Moreover, the total population, N , with
N = S + L1 + I + L2 + R, is assumed to be constant, i.e., the rate of birth and death, µ, are
equal (corresponding to a mean life time of 70 years [12]) and there are no disease-related deaths.
The assumption that the total population N is constant, allows to reduce the control system (1)
from five to four state variables. We decided to maintain the TB model in form (1), using relation
S(t)+L1(t)+I(t)+L2(t)+R(t) = N as a test to confirm the numerical results. The proportion of
population change, in each category, is described by system (1). The initial value of each category,
S(0), L1(0), I(0), L2(0) and R(0), are given in Table 1 and are based on [14].
The values of the rates δ, φ, ω, ωR, σ and τ0 are taken from [12] and the references cited
therein (see Table 1 for the values of the parameters). The parameter δ denotes the rate at which
individuals leave L1 compartment; φ is the proportion of individuals going to compartment I; ω
is the rate of endogenous reactivation for persistent latent infections (untreated latent infections);
ωR is the rate of endogenous reactivation for treated individuals (for those who have undergone
a therapeutic intervention). The parameter σ is the factor that reduces the risk of infection, as
a result of acquired immunity to a previous infection, for persistent latent individuals, i.e., this
factor affects the rate of exogenous reinfection of untreated individuals; while σR represents the
same parameter factor but for treated patients. In our simulations we consider the case where the
susceptibility to reinfection of treated individuals equals that of latents: σR = σ.
The parameter τ0 is the rate of recovery under treatment of active TB (assuming an average
duration of infectiousness of six months). The parameters τ1 and τ2 apply to latent individuals
L1 and L2, respectively, and are the rates at which chemotherapy or a post-exposure vacine is
applied. In [12] different values for these rates are considered: the case where no treatment of latent
infections occur (τ1 = τ2 = 0); the case where there is an immediate treatment of persistent latent
infections (τ2 →∞); or there is a moderate treatment of persistent latent infections (τ2 ∈ [0.1, 1]).
The first and second cases are not interesting from the optimal control point of view. In our
paper we consider, without loss of generality, that the rate of recovery of early latent individuals
under post-exposure interventions is equal to the rate of recovery under treatment of active TB,
τ1 = 2 yr
−1, and greater than the rate of recovery of persistent latent individuals under post-
exposure interventions, τ2 = 1 yr
−1.
It is assumed that the rate of infection of susceptible individuals is proportional to the number of
infectious individuals and the constant of proportionality is β, which is the transmission coefficient.
The basic reproduction number R0, for system (1) in the absence of controls, i.e., in the case
u1 = u2 = 0, is proportional to the transmission coefficient β (see [12]) and is given by
R0 =
δ (ω + φµ) (ωR + µ)
(ωR + τ0 + µ) (δ + µ) (ω + µ)
β
µ
. (2)
To see that the controls can be used to reduce R0, one just needs to follow the same procedure
used to obtain (2) in [12], for the general situation where the controls u1 and u2 are present:
R0(u1, u2) =
δ [(ω + φµ) (ωR + µ) + (ωR + φµ) ǫ2 u2 ]
(ωR + τ0 + µ+ ǫ1 u1 ) (δ + µ) (ω + µ+ ǫ2 u2 )
β
µ
. (3)
For u1 = u2 = 0 (3) reduces to (2), i.e., R0(0, 0) = R0. It should be noted, however, that (2) and
(3) are deduced under the assumption that τ1 = τ2 = 0, which in our investigation is not true:
as already mentioned, we consider τ1 = 2 and τ2 = 1 (see also Table 1). Therefore, we begin by
proving a general formula for R0(u1, u2).
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Proposition 2.1. The basic reproduction number R0(u1, u2) for system (1) is given by
R0(u1, u2) =
ωR (ω + τ2 + µ+ ǫ2 u2 ) τ1 + δ [(ω + φµ) (ωR + µ) + (ωR + φµ) (τ2 + ǫ2 u2 )]
(ωR + τ0 + µ+ ǫ1 u1 ) (δ + τ1 + µ) (ω + τ2 + µ+ ǫ2 u2 )
β
µ
.
(4)
Proof. The system (1) has only one DFE (disease free equilibrium):
(S,L1, I, L2, R) = (N, 0, 0, 0, 0, 0). (5)
We calculate the basic reproduction number R0(u1, u2) using the approach explained with details,
e.g., in [20]. For that we write the right-hand side of system (1) as F − V with
F =


0
β I (S+σ L2+σR R)
N
0
0
0


and
V =


−µN + β I SN + µS
(δ + τ1 + µ)L1
−φ δ L1 − ω L2 − ωR R+ (τ0 + ǫ1 u1 + µ) I
− (1− φ) δ L1 +
β I σ L2
N + (ω + ǫ2 u2 + τ2 + µ)L2
− I Nτ0+I Nǫ1 u1+τ1 L1 N+L2 Nτ2+L2 Nǫ2 u2−σR β I R−RNωR−RNµN

 .
Then we consider the Jacobian matrices associated with F and V :
JF =


0 0 0 0 0
β I
N 0
β (S+σ L2+σR R)
N
β I σ
N
β I σR
N
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0


,
JV =


β I
N + µ 0
β S
N 0 0
0 δ + τ1 + µ 0 0 0
0 −φ δ τ0 + ǫ1 u1 + µ −ω −ωR
0 − (1− φ) δ σ β L2N
β I σ
N + ω + ǫ2 u2 + τ2 + µ 0
0 −τ1 −τ0 − ǫ1 u1 +
σR β R
N −τ2 − ǫ2 u2
β I σR
N + ωR + µ


.
The basic reproduction number (4) is obtained as the spectral radius of the matrix JF × (JV )
−1
at the disease-free equilibrium (5).
Remark 2.1. In the particular case u1 = u2 = 0, Proposition 2.1 improves the result of [12] for
arbitrary values of τ1 and τ2.
It is easy to see that the control u1 has a very important role in the reduction of R0. In
particular, using the control u1 we can always diminish the basic reproduction number: R0(u1, 0) ≤
R0(0, 0) (see Proposition 3.1). The endemic threshold ET at R0 = 1 indicates the minimal
transmission potential that sustains endemic disease, i.e., when R0 < 1 the disease will die out
and for R0 > 1 the disease may become endemic. In Section 5 we take increasing values for β
with R0 > 1.
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Example 2.1. If β = 55, δ = 12, ω = 0.0002, ωR = 0.00002, µ = 1/70, φ = 0.05, ǫ1 = 0.5,
ǫ2 = 0.5, τ0 = 2, τ1 = 2 and τ2 = 1, then the basic reproduction number R0 without controls is
greater than one (R(0, 0) > 1.21) and with u1 = u2 = 1 one is able to change R0 to a desirable
situation: the basic reproduction number is then less than one (R(1, 1) < 0.97).
The total simulation duration, T , is fixed. Following [23, Sec. 5.5], the risk of developing disease
after infection is much higher in the first five years following infection, and decline exponentially
after that. For this reason we take T = 5, in years.
3 Sensitivity of the basic reproduction number
The sensitivity of the basic reproduction number (4) is an important issue because it determines
the model robustness to parameter values. Two parameters have, in different directions, a high
impact on R0: u1 decreases R0 and β increases R0. The sensitivity of R0 with respect to u1 is
given by Proposition 3.1.
Proposition 3.1. The inequality
R0(u1, u2) ≤ R0(0, u2)
holds for any value of the system parameters.
Proof. A direct calculation from (4) shows that
∂R0(u1, u2)
∂u1
≤ 0
for any value of the parameters. Thus, the basic reproduction number decreases with u1.
Remark 3.1. The analogous to Proposition 3.1 for u2 is not true: the basic reproduction number
can decrease or increase with u2 depending on the system parameters.
Let us examine now the sensitivity of R0 with respect to β.
Proposition 3.2. The basic reproduction number R0(u1, u2) increases with β.
Proof. The results follows immediately from the fact that
∂R0(u1, u2)
∂β
> 0
for any value of the parameters.
The sensitivity of a variable (in our case of interest, R0) with respect to model parameters is
sometimes measured by the so called sensitivity index.
Definition 3.1 (cf. [7, 15]). The normalized forward sensitivity index of a variable υ that depends
differentiably on a parameter p is defined by
Υυp :=
∂υ
∂p
×
p
|υ|
. (6)
Note that to the most sensitive parameter p it corresponds a normalized forward sensitivity
index of one or minus one: Υυp = ±1. If Υ
υ
p = +1, an increase (decrease) of p by x% increases
(decreases) υ by x%; if Υυp = −1, an increase (decrease) of p by x% decreases (increases) υ by x%.
From Definition 3.1 and Proposition 2.1, it is easy to derive the normalized forward sensitivity
index of R0 with respect to β and u1.
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Proposition 3.3. The normalized forward sensitivity index of R0 with respect to β is 1, that is,
ΥR0β = 1, while the sensitivity of R0 with respect to u1 is given by
ΥR0u1 = −
ǫ1 u1
ωR + τ0 + µ+ ǫ1 u1
.
Proof. It follows from Proposition 2.1 and (6):
ΥR0β =
∂R0
∂β
×
β
|R0|
= 1,
ΥR0u1 =
∂R0
∂u1
×
u1
|R0|
= −
ǫ1 u1
ωR + τ0 + µ+ ǫ1 u1
.
4 Optimal control problem
In this section we present the optimal control problem, describing our goal and the restrictions
of the epidemic. The aim is to find the optimal values u∗1 and u
∗
2 of the controls u1 and u2, such
that the associated state trajectories S∗, L∗1, I
∗, L∗2, R
∗ are solution of the system (1) in the time
interval [0, T ] with initial conditions S∗(0), L∗1(0), I
∗(0), L∗2(0), R
∗(0), and minimize the objective
functional. Here the objective functional considers the number of active TB infectious individuals
I, the number of persistent latent individuals L2, and the implementation cost of the strategies
associated to the controls ui, i = 1, 2. The controls are bounded between 0 and 1. When the
controls vanish, no extra measures are implemented for the reduction of I and L2; when the
controls take the maximum value 1, the magnitude of the implemented measures, associated to
u1 and u2, take the value of the effectiveness of the controls, ǫ1 and ǫ2, respectively.
We consider the state system (1) of ordinary differential equations in R5 with the set of ad-
missible control functions given by
Ω =
{
(u1(·), u2(·)) ∈ (L
∞(0, T ))2 | 0 ≤ u1(t), u2(t) ≤ 1, ∀ t ∈ [0, T ]
}
.
The objective functional is given by
J(u1(·), u2(·)) =
∫ T
0
[
I(t) + L2(t) +
W1
2
u21(t) +
W2
2
u22(t)
]
dt , (7)
where the constantsW1 andW2 are a measure of the relative cost of the interventions associated to
the controls u1, u2, respectively (see Section 5 for further details). We consider the optimal control
problem of determining (S∗(·), L∗1(·), I
∗(·), L∗2(·), R
∗(·)), associated to an admissible control pair
(u∗1(·), u
∗
2(·)) ∈ Ω on the time interval [0, T ], satisfying (1), the initial conditions S(0), L1(0), I(0),
L2(0) and R(0) (see Table 1) and minimizing the cost function (7), i.e.,
J(u∗1(·), u
∗
2(·)) = min
Ω
J(u1(·), u2(·)) . (8)
The existence of optimal controls (u∗1(·), u
∗
2(·)) comes from the convexity of the cost function
(7) with respect to the controls and the regularity of the system (1) (see, e.g., [6, 11] for existence
results of optimal solutions).
According to the Pontryagin Maximum Principle [18], if (u∗1(·), u
∗
2(·)) ∈ Ω is optimal for the
problem (1), (8) with the initial conditions given in Table 1 and fixed final time T , then there exists
a nontrivial absolutely continuous mapping λ : [0, T ]→ R5, λ(t) = (λ1(t), λ2(t), λ3(t), λ4(t), λ5(t)),
called adjoint vector, such that
S˙ =
∂H
∂λ1
, L˙1 =
∂H
∂λ2
, I˙ =
∂H
∂λ3
, L˙2 =
∂H
∂λ4
, R˙ =
∂H
∂λ5
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and
λ˙1 = −
∂H
∂S
, λ˙2 = −
∂H
∂L1
, λ˙3 = −
∂H
∂I
, λ˙4 = −
∂H
∂L2
, λ˙5 = −
∂H
∂R
, (9)
where function H defined by
H = H(S(t), L1(t), I(t), L2(t), R(t), λ(t), u1(t), u2(t))
= I(t) + L2(t) +
W1
2
u21(t) +
W2
2
u22(t)
+ λ1(t)
(
µN −
β
N
I(t)S(t) − µS(t)
)
+ λ2(t)
(
β
N
I(t) (S(t) + σL2(t) + σRR(t))− (δ + τ1 + µ)L1(t)
)
+ λ3(t) (φδL1(t) + ωL2(t) + ωRR(t)− (τ0 + ǫ1u1(t) + µ)I(t))
+ λ4(t)
(
(1 − φ)δL1(t)− σ
β
N
I(t)L2(t)− (ω + ǫ2u2(t) + τ2 + µ)L2(t)
)
+ λ5(t)
(
(τ0 + ǫ1u1(t))I(t) + τ1L1(t) + (τ2 + ǫ2u2(t))L2(t)− σR
β
N
I(t)R(t)− (ωR + µ)R(t)
)
is called the Hamiltonian, and the minimization condition
H(S∗(t),L∗1(t), I
∗(t), L∗2(t), R
∗(t), λ∗(t), u∗1(t), u
∗
2(t))
= min
0≤u1,u2≤1
H(S∗(t), L∗1(t), I
∗(t), L∗2(t), R
∗(t), λ∗(t), u1, u2)
(10)
holds almost everywhere on [0, T ]. Moreover, the transversality conditions
λi(T ) = 0, i = 1, . . . , 5 ,
hold.
Theorem 4.1. Problem (1), (8) with fixed initial conditions S(0), L1(0), I(0), L2(0) and R(0) and
fixed final time T , admits an unique optimal solution (S∗(·), L∗1(·), I
∗(·), L∗2(·), R
∗(·)) associated to
an optimal control pair (u∗1(·), u
∗
2(·)) on [0, T ]. Moreover, there exists adjoint functions λ
∗
1(·), λ
∗
2(·),
λ∗3(·), λ
∗
4(·) and λ
∗
5(·) such that

λ˙∗1(t) = λ
∗
1(t)
(
β
N I
∗(t) + µ
)
− λ∗2(t)
β
N I
∗(t)
λ˙∗2(t) = λ
∗
2(t) (δ + τ1 + µ)− λ
∗
3(t)φδ − λ
∗
4(t)(1 − φ)δ − λ
∗
5(t)τ1
λ˙∗3(t) = −1 + λ
∗
1(t)
β
N S
∗(t)− λ∗2(t)
β
N (S
∗(t) + σL∗2(t) + σRR
∗(t))
+λ∗3(t) (τ0 + ǫ1u
∗
1(t) + µ) + λ
∗
4(t)σ
β
NL
∗
2(t)− λ
∗
5(t)
(
τ0 + ǫ1u
∗
1(t)− σR
β
NR
∗(t)
)
λ˙∗4(t) = −1− λ
∗
2(t)
β
N I
∗(t)σ − λ∗3(t)ω + λ
∗
4(t)
(
σ βN I
∗(t) + ω + ǫ2u
∗
2(t) + τ2 + µ
)
−λ∗5(t) (τ2 + ǫ2u
∗
2(t))
λ˙∗5(t) = −λ
∗
2(t)σR
β
N I
∗(t)− λ∗3(t)ωR + λ
∗
5(t)
(
σR
β
N I
∗(t) + ωR + µ
)
,
(11)
with transversality conditions
λ∗i (T ) = 0, i = 1, . . . , 5 .
Furthermore,
u∗1(t) = min
{
max
{
0,
ǫ1I
∗ (λ∗3 − λ
∗
5)
W1
}
, 1
}
,
u∗2(t) = min
{
max
{
0,
ǫ2L
∗
2 (λ
∗
4 − λ
∗
5)
W2
}
, 1
}
.
(12)
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Proof. Existence of an optimal solution (S∗, L∗1, I
∗, L∗2, R
∗) associated to an optimal control pair
(u∗1, u
∗
2) comes from the convexity of the integrand of the cost function J with respect to the
controls (u1, u2) and the Lipschitz property of the state system with respect to state variables
(S,L1, I, L2, R) (see, e.g., [6, 11]). System (11) is derived from the Pontryagin maximum principle
(see (9), [18]) and the optimal controls (12) come from the minimization condition (10). For small
final time T , the optimal control pair given by (12) is unique due to the boundedness of the state
and adjoint functions and the Lipschitz property of systems (1) and (11) (see [14] and references
cited therein).
Remark 4.1. Due to the fact that the state system (1) is autonomous, the proof of Theorem 4.1
is valid for any time T and not only for small time T .
5 Numerical results and discussion
In this section we present results of the numerical implementation of optimal control strategies for
the TB model (1) with cost functional (7). We consider variations of some parameters separately,
and interpret the obtained optimal controls and associated optimal state solutions.
Different approaches were used to obtain and confirm the numerical results. One approach
consisted in using IPOPT [27] and the algebraic modeling language AMPL [28]. A second approach
was to use the PROPT Matlab Optimal Control Software [29]. The results coincide with the ones
obtained by an iterative method that consists in solving the system of ten ODEs given by (1) and
(11). For that, first we solve system (1) with a guess for the controls over the time interval [0, T ]
using a forward fourth-order Runge–Kutta scheme and the transversality conditions λi(T ) = 0,
i = 1, . . . , 5. Then, system (11) is solved by a backward fourth-order Runge–Kutta scheme using
the current iteration solution of (1). The controls are updated by using a convex combination of
the previous controls and the values from (12). The iteration is stopped when the values of the
unknowns at the previous iteration are very close to the ones at the present iteration. For more
details see, e.g., [14].
We start comparing the case of minimizing the number of infectious and persistent latent
individuals, I + L2, with and without controls. We consider β = 100, N = 30000, ǫ1 = ǫ2 = 0.5,
W1 = 500,W2 = 50, and the values of the remaining parameters are presented in Table 1. For these
parameter values, R0(0, 0) = 2.2 and R0(1, 1) = 1.76. In Figure 1 we observe that the fraction
of active infectious and persistent latent individuals is lower when controls are considered. More
precisely, at the end of five years, the total number of infectious and persistent latent individuals
I + L2 is 320 when controls are considered, and 1550 without controls. To minimize the total
number of infectious and persistent latent individuals, the optimal control u1 is at the upper
bound during 2.3 years and then, during the remaining 2.7 years, it decreases to the lower bound.
The control u2 is at the upper bound during almost 4.7 years (see Figure 2).
We test the relevance of the optimal control strategies, given by controls u1 and u2, in the
reduction of the fraction of active infected individuals I/N and persistent latent individuals L2/N .
We observe in Figure 3 that both fractions I/N and L2/N are lower when controls are considered,
that is, we can conclude that the implementation of the measures to prevent the failure of treatment
in active TB infectious individuals I and the increase of number of persistent latent individuals
L2, that are identified and put under treatment, are good policies for the achievement of our goal.
Some of the policies associated to the control u1 are the supervision and the support of active
TB infectious individuals I. It is important to ensure that active TB infectious individuals I
complete the treatment, which is difficult due to its duration and second effects. The supervision
can be made, however, not only in hospitals but also paying to specialized people to go to patients
home. This implies higher monetary cost, that is, greater values for Wi, which is illustrated in
Figures 6–8.
In what follows, we consider always strategies using controls u1(t) and u2(t) with t ∈ [0, 5].
Figure 4 illustrates how optimal control strategies change as the transmission coefficient parameter
β varies. We consider four different values for β, 75, 100, 150 and 175, the other parameters
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Symbol Description Value
β Transmission coefficient 75, 100, 150, 175
µ Death and birth rate 1/70 yr−1
δ Rate at which individuals leave L1 12 yr
−1
φ Proportion of individuals going to I 0.05
ω Rate of endogenous reactivation for persistent latent infections 0.0002 yr−1
ωR Rate of endogenous reactivation for treated individuals 0.00002 yr
−1
σ Factor reducing the risk of infection as a result of acquired
immunity to a previous infection for L2 0.25
σR Rate of exogenous reinfection of treated patients 0.25
τ0 Rate of recovery under treatment of active TB 2 yr
−1
τ1 Rate of recovery under treatment of latent individuals L1 2 yr
−1
τ2 Rate of recovery under treatment of latent individuals L2 1 yr
−1
N Total population 10000, 15000, 30000
S(0) Initial number of susceptible individuals 76
120
N
L1(0) Initial number of early latent L1 individuals
37
120
N
I(0) Initial number of infectious individuals 4
120
N
L2(0) Initial number of persistent latent L2 individuals
2
120
N
R(0) Initial number of recovered individuals 1
120
N
T Total simulation duration 5 yr
ǫ1 Efficacy of treatment of active TB I 0.25, 0.5, 0.75
ǫ2 Efficacy of treatment of latent TB L2 0.25, 0.5, 0.75
W1 Weight constant on control u1(t) 150, 250, 500
W2 Weight constant on control u2(t) 50, 150, 250
Table 1: Parameter values.
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Figure 1: (I +L2)/N with and without controls for β = 100, N = 30000, ǫ1 = ǫ2 = 0.5, W1 = 500
and W2 = 50.
taking the values N = 30000, ǫ1 = ǫ2 = 0.5, W1 = 500, and W2 = 50 (the values of the remaining
parameters are presented in Table 1). All the values that β takes correspond to the case where
the disease may become endemic, i.e., R0 > 1. We observe that as the parameter β increases, the
control u1 is at the upper bound for a longer period of time, but the variation on the control u2
is not so significant. In Figure 4 (c) one can see that as β decreases the fraction of infectious and
persistent latent individuals also decreases, as expected.
In Figure 5 the size of the population takes three different values, 30000, 40000 and 60000, and
the controls u1(t) and u2(t) are plotted for t ∈ [0, 5]. One can conclude that the optimal strategies
do not vary significantly: the control u1 is at the upper bound during 2.5 years for N = 40000 and
9
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Figure 2: Controls u1 and u2 for β = 100, N = 30000, ǫ1 = ǫ2 = 0.5, W1 = 500, W2 = 50.
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Figure 3: I/N and L2/N , with and without controls, for β = 100, N = 30000, ǫ1 = ǫ2 = 0.5,
W1 = 500 and W2 = 50.
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(c) (I + L2)/30000
Figure 4: Variation of parameter β (β = 75, 100, 150, 175).
during 2.8 years for N = 60000, and u2 is at the upper bound during 4.7 years for N = 40000 and
during 4.8 years for N = 60000. On the other hand, the controls (u1(·), u2(·)) are such that the
fraction of infectious and persistent latent individuals (I + L2) /N does not depend on the size of
the population.
In Figures 6–8 we present the effect of the weight constantsWi, i = 1, 2, on the controls, where
β = 100, N = 30000, and ǫ1 = ǫ2 = 0.5 (and the other parameters are given by Table 1). We
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Figure 5: Different sizes N of population (N = 30000, 40000, 60000) with β = 100, W1 = 500,
W2 = 50, ǫ1 = ǫ2 = 0.5, and the values of the parameters of Table 1.
assume that the weight constant W1 associated with the control u1 is greater or equal than the
weight constant W2 associated with the control u2, because the cost associated to u1 includes the
cost of holding active infected patients I in the hospital or paying people to supervise the patients,
assuring that they finish their treatment, and the cost associated to u2 is related to the fraction
of persistent latent individuals L2 that is put under treatment. It is clear that when W1 is fixed
and W2 increases, the amount of u2 decreases and u1 remains the same (Figure 6). Analogously,
when W2 is fixed and W1 decreases, the amount of u1 increases (Figure 7). When the weight
constants are equal (Figure 8), both controls vary but, in all the three cases, the optimal control
strategies assure the same value for the fraction of infectious and persistent latent individuals.
Figure 9 illustrates the situation when we vary the measures of control efficacy ǫi, i = 1, 2. We
consider β = 100, N = 30000, W1 = 500, W2 = 50, and ǫ1 = ǫ2 with ǫi = 0.25; 0.5; 0.75, i = 1, 2.
We observe that as the efficacy of the controls increase, the control strategies contribute to the
minimization of the fraction of infectious and persistent latent individuals.
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Figure 6: Variation on the control weights: fix W1 = 500 and vary W2 (W2 = 50, 150, 250).
If we increase the transmission coefficient β, a different scenario occurs. TB rises and then
declines in all of the simulations presented so far. Because TB is clearly already endemic in most
relevant settings, we are not before the peak in Figure 3 and Figures 4–9 (c). But if we are now at
the point where we are after that peak, then TB is declining anyway in all of the figures. However,
if we take, for example, β = 200, this situation does not occur. If we don’t introduce controls, the
number of active infected individuals I and persistent latent individuals L2 increases significantly,
see Figure 10. For these parameter values we have R0(0, 0) = 4.4.
We now show a new situation where the controls have a crucial role: without controls the
number of infected increases, while using the optimal control approach the number of infected
decreases and remains always in a lower level. Let N = 30000, ǫ1 = ǫ2 = 0.5, andW1 = W2 = 500.
Take, for example, β = 250. If the control measures u1 and u2 are not implemented, then the
number of active infected individuals I increases in all the treatment period. However, if the control
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Figure 7: Fix W2 = 50 and decrease W1 (W1 = 500, 250, 150).
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Figure 8: W1 = W2 = 50, 150, 250.
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Figure 9: Variation on ǫi, i = 1, 2 (ǫ1 = ǫ2 = 0.25; 0.5; 0.75).
measures u1 and u2 are used (see Figure 11 for the optimal controls) an important decrease of
active infected individuals is observed (see Figure 12). Without controls the basic reproduction
number is R0(0, 0) = 5.5 and with controls R0(1, 1) = 4.4.
Other cost functionals could be considered in the optimal control problem, namely a cost C
where the category of persistent latent individuals L2 is not considered in (7), that is,
C(u1(·), u2(·)) =
∫ T
0
[
I(t) +
W1
2
u21(t) +
W2
2
u22(t)
]
dt. (13)
However, in Figures 13 and 14 we observe, for different values of β, that when we consider the
cost functional (7), the fraction of active infectious individuals is lower compared with the case
when we consider only active infectious TB individuals I (13).
Let N = 30000, β ∈ {100, 175}, ǫ1 = ǫ2 = 0.5 and W1 = W2 = 500. When we compare the
controls u1 and u2 for the cost functionals J and C, we observe that a bigger effort is required on
12
0 1 2 3 4 5
102
103
104
105
time t
st
at
e 
va
ria
bl
es
 (lo
g s
ca
le)
beta = 200
 
 
I
L2
Figure 10: Number of active infected individuals I and persistent latent individuals L2, β = 200
and N = 30000, when no controls are used.
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Figure 11: Controls u1 and u2 for β = 250; ǫ1 = ǫ2 = 0.5; W1 = W2 = 500; N = 30000.
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Figure 12: Number of active infected individuals with and without controls.
the controls when we propose to minimize I + L2. If our aim is to minimize the active infected
individuals I as well as the cost of the control measures represented by u1 (preventive measures
applied to active infected individuals for a complete treatment with anti-TB drugs), then the
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Figure 13: Comparison of active infectious I and persistent latent L2 individuals for different cost
functionals J and C (β = 100).
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Figure 14: Comparison of active infectious I and persistent latent L2 individuals for different cost
functionals J and C (β = 175).
control u1 never attains the maximum value and the control measure u2 is not required, see
Figure 15.
When β = 175, if we want to minimize the cost functional C then the control u1 attains the
maximum value for approximately 1.1 years; if we want to minimize the cost functional J then
the control u1 attains the maximum value for approximately 3.9 years. Analogously to the case
β = 100, for β = 175 the control measure u2 is not required when we wish to minimize C, see
Figure 16.
The bigger effort on the control measures associated to the cost functional J is justified by
a reduction on the fraction of active infected individuals I and persistent latent individuals L2,
when compared to the case of minimizing C, see Figure 13. This reduction is more significant if
we consider β = 175, see Figure 14.
Finally, we can compare the effect of the implementation of two controls strategies: apply only
the control u1 (supervision and support of TB infectious individuals I); and apply simultaneously
u1 and u2. The treatment of persistent latent individuals L2, for example with a prophylactic
vaccine, is not so usual as the treatment of active infectious individuals, which is one of the
measures proposed by the Direct Observation Therapy (DOT) of World Health Organization
(WHO), but is a valid TB treatment strategy [1, 8]. Observing Figure 17, we conclude that each
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Figure 15: Comparison of controls u1 and u2 for different cost functionals J and C (β = 100).
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Figure 16: Comparison of controls u1 and u2 for different cost functionals J and C (β = 175).
control u1 and u2 implies a reduction on the respective fraction of the population, I and L2.
Moreover, if we choose to minimize the cost function (7), then the best choice is to apply both
controls simultaneously, since the implementation of control u2 does not imply a reduction on the
fraction of active infectious individuals. For this reason, if we choose to minimize the cost function
(13), then the best control strategy is to implement only control u1.
6 Conclusion
The incidence rates of TB have been declining since 2004 worldwide, namely due to prevention and
treatment policies that have been applied in the last years [26]. Mortality rates, at global level, fell
down around 35% between 1990 and 2009, and if the current rate of decline is sustained, by 2015
the target of a 50% reduction can be achieved. The reduction of mortality and incidence rates
depend on the effort at country level to implement control policies. Examples of policies that had
a great success in WHO’s six regions are the DOTS strategy (1995-2005) and its sucessor Stop TB
launched in 2006 (see [26] for further details). In this paper we study a mathematical model for
TB proposed in [12], from the optimal control point of view. Optimal time-dependent prevention
policies, that consider the execution cost, are proposed. We tried different numerical approaches
and we observed that the results are the same, independently of the method used. In particular,
two approaches have been tried: direct and indirect. The direct methods discretize the problem
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Figure 17: Comparison between applying only control u1 and applying the two controls u1 and
u2 simultaneously, with β = 100, ǫ1 = ǫ2 = 0.5, W1 = 500, W2 = 50, and N = 30000.
turning it into a nonlinear optimization problem. Indirect methods use the Pontryagin Maximum
Principle [18] as a necessary condition to find the optimal curve for the respective control: we
substitute (12) into (11) and the obtained system of five equations is solved numerically together
with the five equations of system (1). Figures 1 and 2 show that when controls are considered, the
optimal policies provide a reduction of 1230 active infectious and persistent latent individuals. The
cost execution of the control policies related to control u1 is assumed to be greater or equal to the
one related to control u2 (see Section 5). Figures 7 and 8 show that when the cost of implementation
of control policies related to control u1 decreases, the amount of u1 increases, and when the cost
of implementation of control policies related to control u2 decreases, the amount of u2 increases.
We considered different values for the transmission coefficient parameter β corresponding to the
case where the disease may become endemic. We observe that as the transmission coefficient
increases, the period of time that the control u1 (associated to the effort that prevents the failure
of treatment of active infectious individuals) is at the upper bound also increases, as well as the
fraction of active infectious and persistent latent individuals (Figure 4). We assume that the
total population N is constant and Figure 5 illustrates that optimal control strategies do not vary
significantly when different sizes of population are taken. As we can see in Figure 9, the measures
of the efficacy of control policies ǫ1 and ǫ2 strongly influence the effect of the control policies
related to u1 and u2 on the minimization of the number of active infectious and persistent latent
individuals.
As future work, it would be interesting to consider different values for the parameters τ1
and τ2, and observe the variations on the optimal control strategies. In addition, we intend to
study optimal control strategies for the minimization of the fraction of active infectious and/or
persistent latent individuals, when susceptibility to reinfection of treated individuals differs from
that of latent: σR < σ or σR > σ. Another direction of research consists to study TB/HIV
co-infections.
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